Wei Zhao
Directeur/Bestuurslid bij Hua Medtech Medical Devices (Shanghai) Co., Ltd.
Oorsprong van het eerstegraads netwerk van Wei Zhao
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
6 Dimensions Capital
 6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital is an independent private equity firm headquartered in China. The firm was founded in 2017.
28
| Holding Company | Investment Managers | 28 |
Hua Medtech Medical Devices (Shanghai) Co., Ltd.
 Hua Medtech Medical Devices (Shanghai) Co., Ltd. Medical SpecialtiesHealth Technology Hua Medtech Medical Devices (Shanghai) Co., Ltd. provides stroke diagnosis, treatment, and rehabilitation services. The private company is based in Shanghai, China. The Chinese company was founded in 2017. Wei Zhang has been the CEO of the company since 2020.
4
| Private Company | Medical Specialties | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Wei Zhao via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
Hua Medicine (Shanghai) Co., Ltd.
 Hua Medicine (Shanghai) Co., Ltd. BiotechnologyHealth Technology Hua Medicine (Shanghai) Co., Ltd. is a Chinese biotechnology company that focuses on the clinical needs of diabetic patients. The private company is based in Shanghai, China. The company has brought together high-end talents and scientific and technological resources to develop the world's first dorzagliatin (hms5552) for the treatment of type 2 diabetes. Hua Medicine has conducted two phase III clinical trials in 2019, targeting type 2 diabetes patients who have failed to treat the disease with other medications. The company plans to expand the advanced concepts of personalized therapy and management of diabetes to achieve effective control of diabetes and metabolic diseases and complications. The company was founded in 2011 by Li Chen, who has been the CEO since then. | Biotechnology | Director/Board Member Director/Board Member | |
| WUXI BIOLOGICS (CAYMAN) INC. | Biotechnology | Director/Board Member Chairman | |
Wuxi Biologics Holdings Ltd.
 Wuxi Biologics Holdings Ltd. Financial ConglomeratesFinance Wuxi Biologics Holdings Ltd. functions as an investment holding There is no available country named vg company. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Wuxi New Life Science Investment Ltd.
 Wuxi New Life Science Investment Ltd. Financial ConglomeratesFinance Wuxi New Life Science Investment Ltd. is a Chinese company that provides investment services. The private company is based in Shanghai, China. | Financial Conglomerates | Director/Board Member Director/Board Member | |
LifeMine Therapeutics, Inc.
 LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Founder | |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Chairman | |
Phagelux, Inc.
 Phagelux, Inc. BiotechnologyHealth Technology Phagelux, Inc. develops anti-bacterial solutions. It specializes across multiple fields utilizing various phage and phage-based technologies and solutions. The company is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Director/Board Member | |
Shanghai Syn-the-all Pharmaceutical Co. Ltd.
 Shanghai Syn-the-all Pharmaceutical Co. Ltd. Pharmaceuticals: GenericHealth Technology Shanghai Syn-the-all Pharmaceutical Co. Ltd. engages in the manufacture, research and development of generic drugs. The company offers active pharmaceutical ingredients and finished forms. It provides API process development, small molecule Active pharmaceutical ingredients, analytical development and quality control, antibody drug conjugate services. It serves life science industry. Shanghai Syn-the-all Pharmaceutical was founded on January 23, 2003 and is headquartered in Shanghai, China. | Pharmaceuticals: Generic | Director/Board Member Chairman | |
TenNor Therapeutics Suzhou Ltd.
 TenNor Therapeutics Suzhou Ltd. Pharmaceuticals: GenericHealth Technology TenNor Therapeutics Suzhou Ltd. manufactures pharmaceutical products. It specializes in research and development of new drugs for the treatment of digestive diseases caused by pathogens, including those resistant to available antibiotics. The company was founded by Zhen Kun Ma in 2013 and is headquartered in Suzhou, China. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Wuxi Apptec, Inc.
 Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Data Processing Services | Chief Investment Officer Chief Investment Officer | |
| CSTONE PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CANBRIDGE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Doctorate Degree | |
| JW Biotechnology (Shanghai) Co. Ltd. | Director/Board Member Chairman | ||
| AMBRX INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree Undergraduate Degree | |
| WUXI APPTEC CO., LTD. | Pharmaceuticals: Major | Chief Investment Officer Chief Executive Officer | |
| ADAGENE INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| WUXI PHARMATECH (CAYMAN) INC. (ADR) | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member | |
Fjord Holding LLC
 Fjord Holding LLC Medical/Nursing ServicesHealth Services NextCODE Health LLC provides clinical diagnosis services. It is a sequence-based clinical diagnostics company delivering a powerful solution to genome interpretation and big data challenges. The company was founded in 2013 by Jeffrey Gulcher and Hannes Thor Smarason and is headquartered in Cambridge, MA. | Medical/Nursing Services | Chief Executive Officer Chairman | |
| HUA MEDICINE (SHANGHAI) LTD. | Pharmaceuticals: Major | Founder Director/Board Member | |
Shanghai Yaoming Haide Biotechnology Co., Ltd.
 Shanghai Yaoming Haide Biotechnology Co., Ltd. Medical DistributorsDistribution Services Shanghai Yaoming Haide Biotechnology Co., Ltd. is a private company that sells medical equipment and laboratory equipment. The company is based in Shanghai, China and was founded in 2018. | Medical Distributors | Director/Board Member Director/Board Member | |
| NEUSOFT XIKANG HOLDINGS INC. | Data Processing Services | Director/Board Member | |
China Life Sciences Access Fund LP
 China Life Sciences Access Fund LP Investment ManagersFinance China Life Sciences Access Fund LP is a venture capital fund that operates in the life sciences industry. The private company is based in George Town, Cayman Islands. | Investment Managers | Corporate Officer/Principal | |
| 111, INC. | Medical Distributors | Director/Board Member | |
| FIL Capital Management (Hong Kong) Ltd. | Corporate Officer/Principal | ||
Genuity Science, Inc.
 Genuity Science, Inc. Packaged SoftwareTechnology Services Genuity Science develops cloud based programs to improve health and support wellness. Its products include products include SeqPlus, Clinical Sequence Analyzer, RareCODE CSA, CancerCODE, GeneCODE, RareCODE, FamilyCODE and HealthCODE. The company was founded by Smarason Hannes and Gulcher Jeffrey in 2013 and is headquartered in Shanghai, China. | Packaged Software | Chairman | |
Simcha Therapeutics, Inc.
 Simcha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Simcha Therapeutics, Inc. operates as a biopharmaceutical company that develops engineered interleukin therapy products. The company was founded by Aaron Ring in 2018 and is headquartered in New Haven, CT. | Pharmaceuticals: Major | Director/Board Member | |
| Université Catholique de Louvain | College/University | Doctorate Degree | |
Simcha Therapeutics Holding Co. LLC
 Simcha Therapeutics Holding Co. LLC BiotechnologyHealth Technology Simcha Therapeutics Holding Co. LLC is a biopharmaceutical company which engages in developing an engineered interleukin therapy. The company was founded in 2018 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member | |
| Hua Medicine Technology (Hong Kong) Ltd. | Director/Board Member | ||
Shanghai Hao ParkTechnology Development Co., Ltd.
 Shanghai Hao ParkTechnology Development Co., Ltd. Information Technology ServicesTechnology Services Shanghai Hao Park Technology Development Co., Ltd. is a computer services company based in Shanghai, China. Founded in 1999, the Chinese company provides a range of computer-related services. | Information Technology Services | Chairman | |
| Université de Lille III | College/University | Undergraduate Degree | |
Yangling Jinhai Biotechnology Co., Ltd.
 Yangling Jinhai Biotechnology Co., Ltd. BiotechnologyHealth Technology Yangling Jinhai Biotechnology Co., Ltd. is a company based in Xianyang, China. The Chinese company specializes in biotechnology and offers a range of products, including a vaccine for foot-and-mouth disease in pigs. The company was founded in 2013, and the CEO is Hai Ming Zhang. | Biotechnology | Chief Executive Officer | |
| INNOVENT BIOLOGICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Engine Biosciences Pte Ltd.
 Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Engine Biosciences Pte Ltd. develops novel combinations of genes and drugs for therapeutic and industrial purposes. The company was founded by Timothy Lu and Jeffrey Lu and is headquartered in Singapore. | Biotechnology | Director/Board Member | |
Neusoft Medical Systems Co., Ltd.
 Neusoft Medical Systems Co., Ltd. Medical SpecialtiesHealth Technology Neusoft Medical Systems Co., Ltd. engages in the research, development, manufacturing, and sale of large-scale medical diagnosis and treatment equipment and solutions as well as the provision of related services. Its products include computed tomography systems, magnetic resonance imaging systems, digital subtraction angiography systems, ultrasonic diagnostic equipment, positron emission tomography equipment, radiotherapy products, as well as in vitro diagnostic equipment and reagents. The company was founded on March 6, 1998 and is headquartered in Shenyang, China. | Medical Specialties | Director/Board Member | |
| CUTIA THERAPEUTICS | Pharmaceuticals: Major | Chairman | |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
Curon Biopharmaceutical Ltd.
 Curon Biopharmaceutical Ltd. BiotechnologyHealth Technology Curon Biopharmaceutical Ltd. develops cancer immunotherapies. The company is based in Shanghai, China. and has subsidiaries in Hong Kong. The Chinese company was founded in 2018 by Paul Song. The CEO is Zhihong Chen. | Biotechnology | Founder | |
| University of Paris Jussieu | College/University | Graduate Degree | |
| University of Montreal Law School | College/University | Doctorate Degree | |
| University of Oxford | College/University | Doctorate Degree | |
| Fudan University | College/University | Masters Business Admin |
Statistieken
Internationaal
| China | 24 |
| Verenigde Staten | 11 |
| Kaaimaneilanden | 8 |
| Hongkong | 3 |
| Frankrijk | 3 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 10 |
| Finance | 5 |
| Technology Services | 5 |
| Distribution Services | 3 |
Operationeel
| Director/Board Member | 87 |
| Founder | 23 |
| Private Equity Investor | 22 |
| Chairman | 18 |
| Corporate Officer/Principal | 16 |
Sterkste connecties
| Insiders | |
|---|---|
| Edward Hu | 29 |
| Gregory Verdine | 25 |
| Lian Yong Chen | 24 |
| Ge Li | 23 |
| Hannes Thor Smárason | 11 |
| Qing Sheng Zhu | 11 |
| Xiao Le | 8 |
| Hai Ming Zhang | 7 |
| Lin Ni | 5 |
| Jian Wei Yuan | 3 |
| Er Dong Hua | 3 |
| Jie Zhang | 3 |
| Fay Xing | 3 |
| Dong Ping Lin | 3 |
| Tian Shi Wang | 3 |